Ning Xiaoli, Wang Ziyi, Fei Wenmin, Han Yang, Liu Baoyi, Xu Jingkai, Li Chengxu, Cui Yong, Yu Ruixing
Graduate School of Capital Medical University, Beijing, China.
Department of Dermatology, China-Japan Friendship Hospital, Beijing, China.
J Cosmet Dermatol. 2023 Nov;22(11):3008-3016. doi: 10.1111/jocd.15935. Epub 2023 Jul 18.
To evaluate the efficacy and safety of 1565-nm nonablative fractional laser (NAFL) combined with mucopolysaccharide polysulfate (MPS) cream in the treatment of erythematous acne scars.
A total of 28 subjects with erythematous acne scars from June 2021 to April 2022 were enrolled. One side of each subject's face was randomly assigned to be treated with 1565-nm NAFL (at 2 sessions with four-week intervals) combined with MPS cream (twice daily) for 8 weeks, and the other side with 1565-nm NAFL combined with placebo cream. CBS® images and parameters, dermoscopic images and the quantitative data processed by ImageJ software, and quantitative global scarring grading system (GSS) score were obtained at baseline and after treatment. Subjects' satisfaction assessment was performed after treatment. Adverse events were recorded during treatment.
In CBS® parameters, the red area, red area concentration, and smoothness were improved more significantly on the 1565-nm NAFL combined with MPS cream side than on the 1565-nm NAFL combined with placebo cream side after treatment (p = 0.015, p = 0.013, and p = 0.021). For dermoscopy, both scar area and scar redness achieved a significantly greater percentage of improvement on the side of 1565-nm NAFL combined with MPS cream than the side of 1565-nm NAFL combined with placebo cream after treatment (p = 0.005 and p = 0.041). The reduction of quantitative GSS score and Subjects' satisfaction assessment were similarly superior on the 1565-nm NAFL combined with MPS cream side. Temporary erythema was experienced by all subjects after each 1565-nm NAFL treatment. No subject reported intolerance or allergy to the cream during follow-up.
The combined application of 1565-nm NAFL and MPS cream could be an effective and safe treatment for erythematous acne scars. ImageJ software enables quantitative evaluation of dermoscopic images of acne scars.
评估1565纳米非剥脱性分数激光(NAFL)联合多磺酸粘多糖(MPS)乳膏治疗红斑痤疮瘢痕的疗效和安全性。
纳入2021年6月至2022年4月期间共28例患有红斑痤疮瘢痕的受试者。将每位受试者面部的一侧随机分配接受1565纳米NAFL(分2次治疗,间隔4周)联合MPS乳膏(每日2次)治疗8周,另一侧接受1565纳米NAFL联合安慰剂乳膏治疗。在基线和治疗后获取CBS®图像及参数、皮肤镜图像以及经ImageJ软件处理的定量数据,还有定量整体瘢痕分级系统(GSS)评分。治疗后进行受试者满意度评估。治疗期间记录不良事件。
在CBS®参数方面,治疗后1565纳米NAFL联合MPS乳膏一侧的红色区域、红色区域浓度及光滑度改善程度比1565纳米NAFL联合安慰剂乳膏一侧更显著(p = 0.015、p = 0.013和p = 0.021)。对于皮肤镜检查,治疗后1565纳米NAFL联合MPS乳膏一侧的瘢痕面积和瘢痕发红改善百分比显著高于1565纳米NAFL联合安慰剂乳膏一侧(p = 0.005和p = 0.041)。1565纳米NAFL联合MPS乳膏一侧的定量GSS评分降低及受试者满意度评估同样更优。每次1565纳米NAFL治疗后所有受试者均出现暂时性红斑。随访期间无受试者报告对乳膏不耐受或过敏。
1565纳米NAFL与MPS乳膏联合应用可能是治疗红斑痤疮瘢痕的一种有效且安全的方法。ImageJ软件能够对痤疮瘢痕的皮肤镜图像进行定量评估。